Lobe Sciences (FRA:LOBE) EBIT per Share : €-0.02 (TTM As of Nov. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Lobe Sciences EBIT per Share?

Lobe Sciences's EBIT per Share for the three months ended in Nov. 2024 was €-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Nov. 2024 was €-0.02.

During the past 3 years, the average EBIT per Share Growth Rate was 55.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 46.00% per year. During the past 10 years, the average EBIT per Share Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Lobe Sciences's EBIT per Share or its related term are showing as below:

FRA:LOBE' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -76 Med: 23.1 Max: 55.7
Current: 55.7

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Lobe Sciences was 55.70% per year. The lowest was -76.00% per year. And the median was 23.10% per year.

FRA:LOBE's 3-Year EBIT Growth Rate is ranked better than
92.78% of 1233 companies
in the Biotechnology industry
Industry Median: 8 vs FRA:LOBE: 55.70

Lobe Sciences's EBIT for the three months ended in Nov. 2024 was €-0.46 Mil.

Lobe Sciences EBIT per Share Historical Data

The historical data trend for Lobe Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences EBIT per Share Chart

Lobe Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

EBIT per Share

Get a 7-Day Free Trial

-0.14

-0.13

-0.25

-0.03

-0.02

Lobe Sciences Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
EBIT per Share	Get a 7-Day Free Trial															-0.01	-0.01	-	-0.01	-

Lobe Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Lobe Sciences's EBIT per Share for the fiscal year that ended in Aug. 2024 is calculated as

	EBIT per Share		(A: Aug. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.79	/	122.134
=	-0.02

Lobe Sciences's EBIT per Share for the quarter that ended in Nov. 2024 is calculated as

	EBIT per Share		(Q: Nov. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.456	/	173.702
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02

Lobe Sciences (FRA:LOBE) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Lobe Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (FRA:LOBE) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

LOBEF:USA LOBE:Canada

Address

1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Lobe Sciences Headlines

No Headlines